FDA Adverse Event Malfunction Summary report: N

BINAXNOW COVID-19 AG SELF TEST 2CT

MDR report key: 17477998 · Received August 8, 2023

Report

Report Number
1221359-2023-01322
Event Type
Malfunction
Date Received
August 8, 2023
Date of Event
July 15, 2023
Report Date
August 15, 2023
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QKP
UDI-DI
00811877011408
PMA / PMN Number
EUA210264
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 212542 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 195-160 / LOT 212542, TEST BASE PART NUMBER 195-430WJR / LOT 210055. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. (B)(4). IN CONCLUSION, ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE, HOWEVER IT COULD HAVE POSSIBLY BEEN RELATED TO THE SPECIFIC PATIENT SAMPLE.A3 - GENDER H3 OTHER TEXT : SINGLE-USE, DEVICE DISCARDED.

Additional Manufacturer Narrative · 0

THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION OR UPON RECEIPT OF NEW INFORMATION. H3 OTHER TEXT : SINGLE-USE, DEVICE DISCARDED.

Description of Event or Problem · 0

THE CONSUMER REPORTED SEVEN (7) UNCONFIRMED FALSE NEGATIVE RESULTS WITH THE BINAXNOW COVID-19 ANTIGEN SELF TEST AND BINAXNOW COVID-19 ANTIGEN HOME TEST FOR MULTIPLE TESTS PERFORMED ON DIFFERENT DAYS. THIS MFR. REPORT ADDRESSES TEST FOUR (4) OF SEVEN (7) WHICH OCCURRED ON (B)(6) 2023. REPEAT TESTING (X6) WAS PERFORMED AND GENERATED NEGATIVE RESULTS THROUGH (B)(6) 2023. ADDITIONAL TESTING (X7) WAS PERFORMED WITH NON-ABBOTT TEST (PLATFORM - IHEALTH) AND GENERATED POSITIVE RESULTS THROUGH (B)(6) 2023. ADDITIONAL TESTING (X3) WAS PERFORMED WITH NON-ABBOTT TEST (PLATFORM - DIATRUST) AND GENERATED NEGATIVE RESULTS THROUGH (B)(6) 2023. THE CONSUMER WAS DIAGNOSED WITH COVID-19 ON (B)(6) 2023 AND WAS SYMPTOMATIC (FEVER). ALTHOUGH REQUESTED, NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

Description of Event or Problem · 0

THE CONSUMER REPORTED SEVEN (7) UNCONFIRMED FALSE NEGATIVE RESULTS WITH THE BINAXNOW COVID-19 ANTIGEN SELF TEST AND BINAXNOW COVID-19 ANTIGEN HOME TEST FOR MULTIPLE TESTS PERFORMED ON DIFFERENT DAYS. THIS MFR. REPORT ADDRESSES TEST FOUR (4) OF SEVEN (7) WHICH OCCURRED ON (B)(6) 2023. REPEAT TESTING (X6) WAS PERFORMED AND GENERATED NEGATIVE RESULTS THROUGH (B)(6) 2023. ADDITIONAL TESTING (X7) WAS PERFORMED WITH NON-ABBOTT TEST (PLATFORM - IHEALTH) AND GENERATED POSITIVE RESULTS THROUGH (B)(6) 2023. ADDITIONAL TESTING (X3) WAS PERFORMED WITH NON-ABBOTT TEST (PLATFORM - DIATRUST) AND GENERATED NEGATIVE RESULTS THROUGH (B)(6) 2023. THE CONSUMER WAS DIAGNOSED WITH COVID-19 ON (B)(6) 2023 AND WAS SYMPTOMATIC (FEVER). ALTHOUGH REQUESTED, NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1260616 BINAXNOW COVID-19 AG SELF TEST 2CT CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 212542 00811877011408

Patients

Seq Age Sex Outcome Treatment
1 Male